After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Standard BioTools Inc is $467.18M. A total of 1.01 million shares were traded on the day, compared to an average of 1.83M shares.
In the most recent transaction, Casdin Partners Master Fund, L bought 150,000 shares of LAB for 1.22 per share on Aug 15 ’25. After the transaction, the Director now owns 59,750,000 company shares. In a previous transaction on Aug 14 ’25, Casdin Partners Master Fund, L bought 133,220 shares at 1.21 per share. LAB shares that Director owns now total 59,600,000.
Among the insiders who bought shares, Casdin Partners Master Fund, L acquired of 75,000 shares on Aug 13 ’25 at a per-share price of $1.31. This resulted in the Director holding 59,466,780 shares of LAB after the transaction. In another insider transaction, Kim Hanjoon Alex sold 1,428 shares at $0.94 per share on May 23 ’25. Company shares held by the Chief Financial Officer now total 930,286.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, LAB has a high of $2.32 and a low of $0.92.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. LAB’s latest balance sheet shows that the firm has $28.45M in Cash & Short Term Investments as of fiscal 2021. There were $111.65M in debt and $49.57M in liabilities at the time. Its Book Value Per Share was $1.11, while its Total Shareholder’s Equity was $94.60M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LAB is Buy with a score of 3.50.
